STOCKWATCH
·
Pharmaceuticals
Quarterly Result11 May 2026, 10:31 pm

Abbott India FY26: Revenue ₹6,929.05 Cr, PAT ₹1,552.02 Cr

AI Summary

Abbott India Ltd has announced its audited financial results for the quarter and year ended March 31, 2026. The results, approved by the Board of Directors on May 11, 2026, show a revenue from operations of ₹6,929.05 Cr and a profit after tax of ₹1,552.02 Cr for the year ended March 31, 2026. The auditor's report, issued by M/s. Walker Chandiok & Co. LLP, has an unmodified opinion. The Board Meeting, where the results were approved, commenced at 6.00 pm and concluded at 7.30 pm.

Key Highlights

  • Revenue from operations for FY26 stood at ₹6,929.05 Cr.
  • Profit after tax for FY26 was reported as ₹1,552.02 Cr.
  • Auditor's report by M/s. Walker Chandiok & Co. LLP has an unmodified opinion.
  • The Board approved the results on May 11, 2026.
  • Basic/Diluted EPS stood at ₹730.36 for the year ended March 31, 2026.
ABBOTINDIA
Pharmaceuticals
ABBOTT INDIA LTD.

Price Impact